Archive
Proactive news round-up: Minds + Machines, Kromek Group, Clinigen Group …
A glance at some of the stories on the Proactive newswire today.
Company
ImmuPharma PLC
LON:IMM
ImmuPharma PLC is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides. The company is dedicated to developing an innovative portfolio of peptide-based therapeutic drugs with a focus on autoimmunity/inflammation and anti-infectives.
306 stories · page 13 of 16
ImmuPharma "grossly undervalued", says broker as co updates on trial
Analyst Vadim Alexandre, of the company’s broker Northland Capital, said Wednesday’s update provided “better visibility” on the trial timetable.
ImmuPharma update reveals strong demand to take part in phase III lupus trial
In all 293 patients were screened to take part in the study and 200 were accepted.
Four drug stocks to watch in phase III next year
2017 could be a big year for these four lesser-known junior drug developers
Archive
Proactive news round-up: Abenza, Falcon Oil & Gas, Aviation ...
A glance at some of the stories on the Proactive newswire today
ImmuPharma passes "major milestone" as it completes recruitment for phase III Lupus trial
It has delivered on its plan to have 200 sufferers of the life-threatening auto-immune disease taking part in the study by the end of the year.
FTSE edges higher, small caps help London record 40% gainers, miners sink
FTSE 100 stocks ended higher on Thursday after pulling away from flat positions at midsession while small-caps helped 40% of London’s stocks to gain – one of their best performances this year - but falling prices for copper, zinc and nickel
Archive
Brokers: 25% upside as well as big yield at Imperial Brands
A round-up of some of today's broker commentary
Immupharma among the small cap pharmas in focus on Wednesday
Immupharma among the small cap pharmas in focus on Wednesday, alongside Futura Medical, Horizon Discovery Group, and Summit Therapeutics.
ImmuPharma’s valuation “way too low”
One analyst thinks the drug discoverer could add at least another £1 to its share price
Legal & General revealed as ImmuPharma backer
L&G has a 3.43% stake after participating in the drug developer's well-supported share placing earlier this year
Proactive news highlights: Mosman stars as it acquires producing oil field
Also in the news, Hurricane Energy has started drilling on its latest well in the North Sea, while Premier African hits ‘significant’ lithium grades in Zimbabwe
ImmuPharma tops up funds as Lupuzor trial progresses
Immupharma said that this cash would be used on lupus treatment Lupuzor
Proactive news highlights: Ariana Resources, Cello Group, ImmuPharma, Premier African and more...
Serial small cap promoter David Lenigas gets behind Premier African, Falcon Oil & Gas reports “excellent gas shows”, and slot machine software group Quixant hits the jackpot with half-year results.